DANYELZA NAXITAMAB Trademark

Trademark Overview


On Tuesday, January 7, 2020, a trademark application was filed for DANYELZA NAXITAMAB with the United States Patent and Trademark Office. The USPTO has given the DANYELZA NAXITAMAB trademark a serial number of 88749157. The federal status of this trademark filing is REGISTERED as of Tuesday, December 8, 2020. This trademark is owned by Y-mAbs Therapeutics, Inc. The DANYELZA NAXITAMAB trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations and substances for the treatment of cancer; Pharmaceutical preparations and substances for the prevention of cancer

Research and development services in the field of antibodies; research and development services in the field of antibody technology; laboratory research and analysis services relating to the production of antibodies; scientific and technological services, namely, scientific research, analysis, and testing in the field of antibodies, and research and design relating thereto; industrial analysis and research services in the field of antibodies
danyelza naxitamab

General Information


Serial Number88749157
Word MarkDANYELZA NAXITAMAB
Filing DateTuesday, January 7, 2020
Status700 - REGISTERED
Status DateTuesday, December 8, 2020
Registration Number6214682
Registration DateTuesday, December 8, 2020
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, September 22, 2020

Trademark Statements


Description of MarkThe mark consists of the stylized, capitalized, teal word "DANYELZA" with three stacked V-shapes emanating from the top of the letter "Y", with the first in purple, the second in light green, and the third in the same teal color. Left-justified beneath the word "DANYELZA", in all lower-case letters and in a different font, is the word "NAXITAMAB" in gray.
Goods and ServicesPharmaceutical preparations and substances for the treatment of cancer; Pharmaceutical preparations and substances for the prevention of cancer
Indication of Colors claimedThe color(s) teal, purple, light green, and gray is/are claimed as a feature of the mark.
Disclaimer with Predetermined Text"NAXITAMAB"
Goods and ServicesResearch and development services in the field of antibodies; research and development services in the field of antibody technology; laboratory research and analysis services relating to the production of antibodies; scientific and technological services, namely, scientific research, analysis, and testing in the field of antibodies, and research and design relating thereto; industrial analysis and research services in the field of antibodies

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 10, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, January 10, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameY-mAbs Therapeutics, Inc
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew York, NY 10169

Party NameY-mAbs Therapeutics, Inc
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10169

Party NameY-mAbs Therapeutics, Inc
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10169

Trademark Events


Event DateEvent Description
Tuesday, December 8, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, September 22, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 22, 2020PUBLISHED FOR OPPOSITION
Wednesday, September 2, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, August 19, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 18, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 18, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 18, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, July 21, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, July 21, 2020NON-FINAL ACTION E-MAILED
Tuesday, July 21, 2020NON-FINAL ACTION WRITTEN
Monday, July 20, 2020PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, June 23, 2020WITHDRAWN FROM PUB - OG REVIEW QUERY
Wednesday, June 10, 2020ELECTRONIC RECORD REVIEW COMPLETE
Friday, June 5, 2020ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Tuesday, June 2, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 2, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 2, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 27, 2020TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, May 11, 2020NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, May 11, 2020LETTER OF SUSPENSION E-MAILED
Monday, May 11, 2020SUSPENSION LETTER WRITTEN
Friday, May 8, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 8, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 7, 2020ASSIGNED TO LIE
Monday, May 4, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 26, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, March 26, 2020NON-FINAL ACTION E-MAILED
Thursday, March 26, 2020NON-FINAL ACTION WRITTEN
Thursday, March 26, 2020ASSIGNED TO EXAMINER
Saturday, January 11, 2020NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, January 10, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, January 10, 2020NEW APPLICATION ENTERED